Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-584-7 | CAS number: 108-45-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral: ALD; rat; gavage; reliability = 2; CLASSIFIED: Cat 4.
Dermal: ALD; rabbit; reliability = 2; CLASSIFIED: Cat 4. [CAS# 95-54-5]
Inhalation: 4-hr LC50; rat; reliability = 2; CLASSIFIED: Cat 4.
Dermal ALD = 1500 mg/kg
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- Only one animal per dose level.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- other: Crl:CD BR
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Raleigh, North Carolina
- Age at study initiation: 7 weeks
- Weight at study initiation: 239-297 g
- Housing: individually in suspended stainless steel, wire-mesh cages
- Diet (e.g. ad libitum): Purina Rodent Chow #5002 ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23± 1°C
- Humidity (%): 50% ± 10%
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 7/18/95 To: 8/10/95 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test substance was suspended in deionized water and administered to 1 rat per dose rate by intragastric intubation. Rats were administered doses ranging from 130 to 670 mg/kg-bw in increments of approximately 50%. Additionally, 1 rat was dosed at 2300 mg/kg. The dosing day was test day one; post exposure day 14 was test day 15.
- Doses:
- Dosage (mg/kg): 130, 200, 300, 450, 670, 2300
Dose vol (mL): 0.18, 0.30, 0.42, 0.61, 0.80, 2.8
Suspension (mg/L): 200, 200, 200, 200, 200, 200 - No. of animals per sex per dose:
- 1 rat per dose level
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Following administration the rats were observed for clinical signs of toxicity. All surviving rats were weighed and observed daily until toxicity subsided up to test day 15.
- Necropsy of survivors performed: no - Sex:
- male
- Dose descriptor:
- other: Approximate Lethal Dose (ALD)
- Effect level:
- 450 mg/kg bw
- Mortality:
- The lowest dose of the test substance which resulted in death of a test animal was 450 mg/kg. The rat dosed at 450 mg/kg was found dead by day 2. Deaths also occurred in rats treated at 670 and 2300 mg/kg. The rat treated at 670 mg/kg was found dead 2 days after dosing. The rat treated at 2300 mg/kg was found dead 1 day after dosing.
- Clinical signs:
- other: NONLETHAL DOSES: Lethargy was observed in the rats treated at 130, 200, and 300 mg/kg approximately 1 hour after dosing. Ruffled fur was observed in rats treated at 200 or 300 mg/kg up to 3 days. LETHAL DOSES: Lethargy was observed in the rats treated at
- Gross pathology:
- Pathological examinations were not performed.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under the conditions of this study, the ALD for the test substance was 450 mg/kg of body weight.
- Executive summary:
The test substance was administered as a single oral dose by intragastric intubation to male rats. Rats were found dead up to 2 days after dosing. Clinical signs of toxicity were observed in lethally and nonlethally dosed animals. Under the conditions of this test, the ALD was 450 mg/kg of body weight.
Reference
Dosage (mg/kg) |
Dose Volume (mL) |
Suspension (mg/mL) |
Initial body weight (g) |
Mortality |
130 |
0.18 |
200 |
272 |
No |
200 |
0.30 |
200 |
297 |
No |
300 |
0.42 |
200 |
282 |
No |
450 |
0.61 |
200 |
273 |
Yes |
670 |
0.80 |
200 |
239 |
Yes |
2300 |
2.8 |
200 |
240 |
Yes |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 450 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- partical size distribution not monitored; temperature, humidity, and pressure in chambers not reported
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- other: Crl:CD
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
-Age at study initiation: 7-8 weeks
- Weight at study initiation: 236 - 278 grams
- Fasting period before study: not reported
- Housing: in pairs in 8"x8"x14" stainless steel cages
- Diet (e.g., ad libitum): ad libitum
- Water (e.g., ad libitum): ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
-Temperature (ºC): not reported
- Humidity (%): not reported
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): not reported - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: Nitrogen
- Details on inhalation exposure:
- Animals were exposed nose-only for single 4-hour periods to atmospheres containing MPD.
Generation: The test material was heated (146-188 ºC) in a round bottom flask. Heated nitrogen (52-75 ºC) was blown through the flask, sweeping MPD vapors into a dilution air stream. Prior to chamber entry, oxygen was added to this mixture to assure a final chamber O2 concentration >20%. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Test atmospheres were sampled by drawing chamber atmosphere through a fritted glass impinger containing methanol as the trapping solvent. Samples were analyzed on a Hewlett-Packard 5700A Gas Chromotograph equipped with a flame ionization detector.
- Duration of exposure:
- 4 h
- Concentrations:
- Mean: 0.72, 2.0, 3.2, 3.9 mg/L
- No. of animals per sex per dose:
- 10
- Control animals:
- not specified
- Details on study design:
- During exposure all rats were observed, clinical signs noted, and chamber oxygen content and temperature monitored. Following exposure, all surviving rats were weighed and observed for 14 days.
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 3.2 mg/L air (analytical)
- 95% CL:
- > 2.6 - < 4.1
- Exp. duration:
- 4 h
- Sex:
- male
- Dose descriptor:
- other: LOAEL
- Effect level:
- 0.72 mg/L air
- Exp. duration:
- 4 h
- Remarks on result:
- other: At all concentrations, rats exhibited red ocular and nasal discharge.
- Mortality:
- Deaths occurred 1-7 days post exposure.
- Clinical signs:
- other: At all concentrations, rats exhibited red ocular and nasal discharge. Rats at all concentrations showed hair loss and wet perineum. Lung noise, brown stained fur, pallor, and tremors were observed at concentrations ≥ 2.0 mg/L. Labored breathing, dry re
- Body weight:
- At all concentrations, rats exhibited moderate to severe weight loss for 1-3 days followed by weight gain.
- Other findings:
- Upon contact with the cool dilution air, the test substance's vapors condensed into an aerosol. The resulting atmosphere was visible to the unaided eye. Chamber temperature was ≤ 31 ºC and oxygen content was ≥ 20% for all exposures.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- 4-hour LC50 = 3.2 mg/L
- Executive summary:
An inhalation Median Lethal Concentration for the test substance was determined in male Crl:CD®rats given single 4 -hour exposures. The calculated LC50 is 3.2 mg/L with 95% confidence limits of 2.6 and 4.1 mg/L.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 3 200 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- Additional documentation, provided within the IUCLID Assessment Reports (Section 13), supports the read-across approach.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- only 1 animal per dose level, only one sex tested, necropsy on only 7 of the 9 animals conducted
- GLP compliance:
- not specified
- Species:
- rabbit
- Strain:
- other: albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: Not reported
- Weight at study initiation: 2.5-3.0 g
- Fasting period before study: None
- Housing: Not reported
- Diet (e.g. ad libitum): Not reported
- Water (e.g. ad libitum): Not reported
- Acclimation period: Not reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Not reported
- Humidity (%): Not reported
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): Not reported - Type of coverage:
- occlusive
- Vehicle:
- other: hydrophilic ointment or polypropylene glycol
- Details on dermal exposure:
- TEST SITE: Rabbits were clipped at the trunk and fitted with collars.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): After 24 hours contact, wrappings were removed and the treated areas were washed with water and dried.
TEST MATERIAL
- For solids, paste formed: Yes; material suspended in polypropylene glycol and applied through a single layer of gauze wrapped around the clipped trunk. For higher doses, a 50% paste of the material in hydrophilic ointment, U.S.P., was applied directly to the clipped skin without gauze. After application, all rabbits were then wrapped with impervious film, gauze, and elastic bandage.
- Duration of exposure:
- 24 hours
- Doses:
- 450, 670, 1000, 1500 (in polypropylene glycol), 1500, 2250 (yellow brown paste), 2250 (orange paste), 7500 and 11000 mg/kg
- No. of animals per sex per dose:
- one
- Control animals:
- no
- Details on study design:
- Animals were observed for 14 days before sacrifice. Necropsies were done on 7 of the 9 animals treated, and major tissues of 6 rabbits were saved for histopathological examination. No-necropsy rabbits: dosed at 11000 mg/kg and at 1500 mg/kg of the test substance in hydrophilic ointment; necropsy only - rabbit dosed at 1500 mg/kg of the test substance in polypropylene glycol.
Tissues examined included kidney, liver, trachea, lung, brain, testes, bone marrow, spleen, thymus, gastrointestinal tract and skin. - Sex:
- male
- Dose descriptor:
- other: Approximate Lethal Dose (ALD)
- Effect level:
- 1 500 mg/kg bw
- Mortality:
- Dose Level Mortality Ratio
(mg/kg)
450 (in 50% H.O.): 0/1
670 (in 50% H.O.): 0/1
1000 (in 50% H.O.): 0/1
1500 (in 15% DMP): 0/1
1500 (in 50% H.O.): 1/1
2250 (in 50% H.O.)
yellow brown paste: 0/1
2250 (in 50% H.O.)
orange paste: 1/1
7500 (in 50% H.O.): 1/1
11,000 (in 50% H.O.): 1/1 - Clinical signs:
- other: Clinical signs of toxicity observed included hematuria and abnormally dark urine, hyperemic eyelids, salivation, and debility. Local signs: Irritation in most cases was at least partially obscured by residual dye. However, the rabbit dosed at 1000 mg
- Gross pathology:
- The following pathologic changes were observed at lethal doses:
Bladder - distended with red-tinged urine (gross exam)
Kidney - congestion (gross exam), inflammation and papillary necrosis (7500 mg/kg)
Liver - necrosis (2250 mg/kg)
Spleen - atrophy of lymphoid elements
Skin - necrosis of epithelium of deeper portions of hair follicles
Bone marrow - generalized necrosis
Thymus - lymphocytolysis
Small intestine - degeneration
The following pathologic changes were observed at non-lethal doses:
Kidney - papillary necrosis (2250 mg/kg)
Thymus - lymphoid atrophy at doses above 450 mg/kg
Bone marrow - generalized necrosis (2250 and 1000 mg/kg with regenerative response at 1000 mg/kg) - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Dermal ALD = 1500 mg/kg
- Executive summary:
The Approximate Lethal Dose (ALD) was 1500 mg/kg for rabbits when the test material was administered as 50% paste in hydrophilic ointment, U.S.P. Clinical signs of toxicity included hematuria and abnormally dark urine, hyperemic eyelids, salivation, and debility. Pathologic examination was done in most cases and showed frequent tissue changes in kidney, liver, bone marrow, lymphoid tissue, small intestine and skin. Local reaction was frequently obscured by the color of the test material; however, temporary moderate to mild irritation from occluded 24 hour contact was sometimes noted. In general, the orange-brown fraction appeared to be more toxic than the yellow-brown fraction in the skin absorption test.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 1 500 mg/kg bw
Additional information
The substance has a rat ALD value of 450 mg/kg, and a rat 4 -hour LC50 value of 3.2 mg/L (3200 mg/m3). In the acute inhalation toxicity test, rats exhibited red ocular and nasal discharge at all concentrations tested (LOAEL = 0.72 mg/L (720 mg/m3)). The structurally similar substance, o-phenylenediamine (CAS 95-54-5), was used as a surrogate for acute dermal data. o-Phenylenediamine has a rabbit ALD value of 1500 mg/kg.
Justification for classification or non-classification
Based on the rat 4-hour LC50 of 3.2 mg/L (3200 mg/m3), the rat oral ALD value of 450 mg/kg, and the rabbit dermal ALD value of 1500 mg/kg, the test substance is classified as Cat 4 (harmful if swallowed) for acute oral, Cat 4 (harmful in contact with skin) for acute dermal, and Cat 4 (harmful if inhaled) for acute inhalation according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008. Although, this classification deviates from the harmonized classification, the harmonized classification will be adhered as it is stricter.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.